Literature DB >> 2364365

The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder.

M Younes1, J Sussman, L D True.   

Abstract

The initial biopsy specimens from 50 patients with high-grade invasive transitional cell carcinoma of the urinary bladder were evaluated for depth of invasion. Stages were assigned according to the following system: T1A, invasion of connective tissue superficial to the level of the muscularis mucosae; T1B, invasion to the level of the muscularis mucosae; T1C, invasion through the level of the muscularis mucosae but superficial to the muscularis propria; and B, invasion into the muscularis propria. Follow-up from the Yale Tumor Registry at a median time of 4.6 years showed that tumors invasive to levels T1A and T1B had a 75% 5-year survival, but tumors invasive through the level of the muscularis mucosae but apparently superficial to the muscularis propria (level T1C) had an 11% 5-year survival, which was comparable with the survival of patients with tumors invasive of the muscularis propria. This study suggests the prognostic importance of assessing the depth of invasion in initial biopsy specimens, even when the specimens lack a muscularis propria.

Entities:  

Mesh:

Year:  1990        PMID: 2364365     DOI: 10.1002/1097-0142(19900801)66:3<543::aid-cncr2820660323>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  ACP Broadsheet 130: November 1991. Gross examination of bladder specimens.

Authors:  M C Parkinson; C Fisher
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

2.  SIU-ICUD on bladder cancer: pathology.

Authors:  Eva Compérat; Marek Babjuk; Ferran Algaba; Mahul Amin; Fadi Brimo; David Grignon; Donna Hansel; Ondra Hes; Bernard Malavaud; Victor Reuter; Theo van der Kwast
Journal:  World J Urol       Date:  2018-09-14       Impact factor: 4.226

3.  [Non-invasive and invasive urothelial tumours: special challenges in uropathological diagnostics].

Authors:  N T Gaisa; K Lindemann-Docter
Journal:  Urologe A       Date:  2013-07       Impact factor: 0.639

Review 4.  A practical guide to bladder cancer pathology.

Authors:  Eva Compérat; Justine Varinot; Julien Moroch; Caroline Eymerit-Morin; Fadi Brimo
Journal:  Nat Rev Urol       Date:  2018-01-31       Impact factor: 14.432

Review 5.  Prognostic factors in superficial bladder cancer.

Authors:  D K Chopin; Z Popov; V Ravery; J Bellot; A Hoznek; J J Patard; C C Abbou; M Colombel
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

6.  [Non-muscle-invasive high-grade bladder cancer].

Authors:  G Gakis; A Stenzl; T Horn; J E Gschwend; W Otto; M Burger
Journal:  Urologe A       Date:  2015-04       Impact factor: 0.639

7.  The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification.

Authors:  J C Angulo; J I Lopez; N Flores; J D Toledo
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  Vascular plexus is a differentation criterion for muscularis mucosa from muscularis propria in small biopsies and transurethral resection materials of urinary bladder?

Authors:  Abdullah Aydin; Ramazan Uçak; Metin Karakök; Muhammed Emin Güldür; Nazim Emrah Koçer
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

9.  Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history.

Authors:  Erik Pasin; David Y Josephson; Anirban P Mitra; Richard J Cote; John P Stein
Journal:  Rev Urol       Date:  2008

10.  Prognostic role of substaging in T1G3 transitional cell carcinoma of the urinary bladder.

Authors:  Vincenzo DE Marco; Maria Angela Cerruto; Carolina D'Elia; Matteo Brunelli; Oscar Otte; Anila Minja; Claudio Luchini; Giovanni Novella; Stefano Cavalleri; Guido Martignoni; Walter Artibani
Journal:  Mol Clin Oncol       Date:  2014-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.